Literature DB >> 11540136

Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance.

M Hendrix1, E S Priestley, G F Joyce, C H Wong.   

Abstract

The specificity of neomycin B and related aminoglycoside antibiotics in their interaction with the Rev responsive element (RRE) of HIV-1 mRNA has been studied by directly observing the aminoglycoside-RNA complexes using surface plasmon resonance. Several different RNA sequences, each with a biotin tag, have been prepared using T7 RNA polymerase-catalyzed transcription of synthetic DNA templates and have been immobilized on a streptavidin-coated surface for the binding study. The results indicate that neomycin B is not specific for the G-rich bubble region in RRE. Rather, it appears to interact with three different sites, each with a submicromolar dissociation constant, within the 67-nucleotide domain II of RRE. Further analysis of neomycin B binding with three short synthetic RNA hairpins showed binding with submicromolar affinity and 1:1 stoichiometry in each case. This suggests that neomycin B may generally bind with this affinity to regular A-form RNA or hairpin loops. The approach described here is generally useful for understanding the fundamental interactions involved in the specific recognition of nucleic acids by small molecules which is the basis of rational drug design.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 11540136     DOI: 10.1021/ja964290o

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  33 in total

Review 1.  Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance.

Authors:  L P Kotra; J Haddad; S Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

Review 2.  RNA Structural Differentiation: Opportunities with Pattern Recognition.

Authors:  Christopher S Eubanks; Amanda E Hargrove
Journal:  Biochemistry       Date:  2018-12-18       Impact factor: 3.162

3.  Radiative decay engineering 3. Surface plasmon-coupled directional emission.

Authors:  Joseph R Lakowicz
Journal:  Anal Biochem       Date:  2004-01-15       Impact factor: 3.365

4.  Using pyrene-labeled HIV-1 TAR to measure RNA-small molecule binding.

Authors:  Kenneth F Blount; Yitzhak Tor
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

5.  Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.

Authors:  Prakash B Palde; Leslie O Ofori; Peter C Gareiss; Jaclyn Lerea; Benjamin L Miller
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

6.  A modified fluorescent intercalator displacement assay for RNA ligand discovery.

Authors:  Papa Nii Asare-Okai; Christine S Chow
Journal:  Anal Biochem       Date:  2010-09-21       Impact factor: 3.365

7.  Complete thermodynamic characterization of the multiple protonation equilibria of the aminoglycoside antibiotic paromomycin: a calorimetric and natural abundance 15N NMR study.

Authors:  Christopher M Barbieri; Daniel S Pilch
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

8.  Integron-Derived Aminoglycoside-Sensing Riboswitches Control Aminoglycoside Acetyltransferase Resistance Gene Expression.

Authors:  Shasha Wang; Weizhi He; Wenxia Sun; Jun Zhang; Yaowen Chang; Dongrong Chen; Alastair I H Murchie
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

9.  Differentiation and classification of RNA motifs using small molecule-based pattern recognition.

Authors:  Giacomo Padroni; Christopher S Eubanks; Amanda E Hargrove
Journal:  Methods Enzymol       Date:  2019-06-13       Impact factor: 1.600

10.  Two-dimensional combinatorial screening identifies specific 6'-acylated kanamycin A- and 6'-acylated neamine-RNA hairpin interactions.

Authors:  Olga Aminova; Dustin J Paul; Jessica L Childs-Disney; Matthew D Disney
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.